NYSE: GLS - Gelesis Holdings, Inc.

Yield per half year: -94.93%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Gelesis Holdings, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Gelesis Holdings, Inc.

Gelesis Holdings Inc., коммерческая биотерапевтическая компания, разрабатывающая биомимикрию для лечения генеза ожирения и хронических заболеваний, связанных с желудочно-кишечным трактом. Компания также предоставляет PLENITY, пероральное, не стимулирующее и несистемное средство для контроля веса. Кроме того, он предлагает продукт для лечения ожирения и избыточного веса, а также потенциальные методы лечения неалкогольной жировой болезни печени/неалкогольного стеатогепатита, диабета 2 типа и GS500 для функционального запора. Gelesis Holdings Inc.

more details
была зарегистрирована в 2006 году и имеет штаб-квартиру в Бостоне, штат Массачусетс.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2022-01-13
ISIN US36850R2040
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.gelesis.com
Цена ао 0.202
Change price per day: +0% (0.0135)
Change price per week: +22.73% (0.011)
Change price per month: +12.5% (0.012)
Change price per 3 month: -95.54% (0.303)
Change price per half year: -94.93% (0.2663)
Change price per year: -99.74% (5.28)
Change price per 3 year: +0% (0.0135)
Change price per 5 year: +0% (0.0135)
Change price per 10 year: +0% (0.0135)
Change price per year to date: -95.25% (0.2845)
All parameters

Underestimation

Title Value Grade
P/S 2.13 7
P/BV 3.68 5
P/E 0 0
EV/EBITDA -0.65 0
Total: 5.25

Efficiency

Title Value Grade
ROA, % -51.79 0
ROE, % -552.36 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.5309 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 21.26 4
Yield Ebitda, % 36.85 5
Yield EPS, % -84.21 0
Total: 4.4
More

Institutions Volume Share, %
Vanguard Group, Inc. (The) 2944423 4.02
Allianz Asset Management GmbH 2563876 3.5
Vitruvian Partners, LLP 1876106 2.56
Neuberger Berman Group, LLC 1107985 1.51
Blackrock Inc. 799156 1.09
Northeast Financial Consultants Inc 395035 0.54
Geode Capital Management, LLC 203376 0.28
Millennium Management LLC 173619 0.24
State Street Corporation 161860 0.22
Northern Trust Corporation 120924 0.16

ETF Share, % Profitability for 1 year, % Dividends, %
WisdomTree Emerging Markets SmallCap Dividend Fund 0.08637 1.35 5.00999
iShares MSCI India Small-Cap ETF 0.08419 0.4625 0.96163
WisdomTree Emerging Markets High Dividend Fund 0.02909 4.18 7.38751
SPDR S&P Emerging Markets Small Cap ETF 0.02176 5.46 3.03583
WisdomTree India Earnings Fund 0.01581 5.23 1.65591
Avantis Emerging Markets Equity ETF 0.01146 8.77 3.60513



Head Job title Payment Year of birth
Mr. Yishai Zohar Founder, Pres, CEO & Director 689.95k 1963 (62 years)
Mr. Elliot Maltz CPA CFO & Treasurer 486.26k 1985 (40 years)
Dr. David Pass Pharm.D. COO & Chief Commercial Officer N/A 1969 (56 years)
Dr. Elaine Chiquette Pharm.D. Chief Scientific Officer N/A 1967 (58 years)
Ms. Joy Bauer M.S., MS, RDN Chief Nutrition Officer of Plenity N/A

Address: United States, Boston. MA, 501 Boylston Street - open in Google maps, open in Yandex maps
Website: https://www.gelesis.com